Lemtrada, The Drug Fighting Against Multiple Sclerosis Relapse Approved by FDA

November 15, 2014 10:24 PM

11 0

The Food and Drug Administration (FDA) has finally decided to allow Lemtrada, a drug that fights against Multiple Sclerosis, to be marketed inside the U.S. Lemtrada has already been approved by the European Medicines Agency and declared safe for usage inside Australia, Canada and the European Union.

Lemtrada was initially supposed to go on the market in December but the FDA rejected the drug because of too many health risks.

Read more

To category page